Dimensional Fund Advisors LP Has $20.98 Million Position in RTI Surgical Inc (RTIX)
Dimensional Fund Advisors LP increased its stake in shares of RTI Surgical Inc (NASDAQ:RTIX) by 2.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,662,902 shares of the medical equipment provider’s stock after buying an additional 101,811 shares during the quarter. Dimensional Fund Advisors LP owned 7.35% of RTI Surgical worth $20,983,000 at the end of the most recent reporting period.
Several other institutional investors also recently bought and sold shares of the stock. Schwab Charles Investment Management Inc. increased its holdings in RTI Surgical by 16.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 125,900 shares of the medical equipment provider’s stock valued at $580,000 after purchasing an additional 17,600 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of RTI Surgical by 6.4% during the second quarter. Bank of New York Mellon Corp now owns 245,573 shares of the medical equipment provider’s stock worth $1,130,000 after purchasing an additional 14,806 shares during the period. Russell Investments Group Ltd. grew its stake in shares of RTI Surgical by 299.0% during the third quarter. Russell Investments Group Ltd. now owns 307,067 shares of the medical equipment provider’s stock worth $1,383,000 after purchasing an additional 230,103 shares during the period. Victory Capital Management Inc. grew its stake in shares of RTI Surgical by 33.1% during the third quarter. Victory Capital Management Inc. now owns 342,051 shares of the medical equipment provider’s stock worth $1,539,000 after purchasing an additional 85,040 shares during the period. Finally, Rutabaga Capital Management LLC MA lifted its holdings in RTI Surgical by 2.3% during the third quarter. Rutabaga Capital Management LLC MA now owns 1,406,388 shares of the medical equipment provider’s stock worth $6,329,000 after acquiring an additional 31,098 shares in the last quarter. Institutional investors and hedge funds own 69.79% of the company’s stock.
RTIX has been the topic of several recent analyst reports. BidaskClub upgraded RTI Surgical from a “sell” rating to a “hold” rating in a report on Tuesday, September 25th. ValuEngine lowered RTI Surgical from a “buy” rating to a “hold” rating in a report on Tuesday, November 27th.
NASDAQ:RTIX opened at $3.94 on Friday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.35 and a current ratio of 3.59. The stock has a market capitalization of $247.50 million, a P/E ratio of 79.20 and a beta of 1.33. RTI Surgical Inc has a 52-week low of $3.51 and a 52-week high of $5.10.
RTI Surgical (NASDAQ:RTIX) last posted its earnings results on Thursday, November 1st. The medical equipment provider reported $0.03 EPS for the quarter, beating the consensus estimate of $0.01 by $0.02. RTI Surgical had a positive return on equity of 4.04% and a negative net margin of 3.91%. The company had revenue of $69.06 million for the quarter, compared to the consensus estimate of $70.09 million. On average, analysts anticipate that RTI Surgical Inc will post 0.11 earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: “Dimensional Fund Advisors LP Has $20.98 Million Position in RTI Surgical Inc (RTIX)” was first published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://theolympiareport.com/2019/01/12/dimensional-fund-advisors-lp-has-20-98-million-position-in-rti-surgical-inc-rtix.html.
RTI Surgical Profile
RTI Surgical, Inc, together with its subsidiaries, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and other tissues, as well as bovine and porcine animal tissues to produce allograft and xenograft implants by using its proprietary BIOCLEANSE, TUTOPLAST, and CANCELLE SP sterilization processes.
Recommended Story: The Structure of a Futures Contract
Receive News & Ratings for RTI Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical and related companies with MarketBeat.com's FREE daily email newsletter.